Would you offer definitive radiotherapy for prostate cancer (or another solid organ malignancy) to a patient on maintenance Rituximab for lymphoma?  

Good question and a somewhat increasingly common issue in the general sense of patients with overlapping hematologic and prostate malignancies. For starters, I would think hard about the risk group of this patient and competing risks. If this patient has an aggressive or relapsed lymphoma with ...

I agree with Dr. @Janopaul-Naylor's answer. I always recommend a thorough consideration of competing risk when considering treating prostate cancer in the setting of concurrent malignancy. Active surveillance will likely be the preferred option for many, but not all, of these patients.If you have de...